Surgeons' volume of colorectal cancer procedures and collaborative decision-making about adjuvant therapies

Annals of Surgery

Volumn 250, Issue 6, 2009, Pages 895-900

  Rogers, Selwyn O ^a,b   Ayanian, John Z ^b,c,d   Ko, Clifford Y ^a   Kahn, Katherine L ^e,f   Zaslavsky, Alan M ^d   Sandler, Robert S ^g   Keating, Nancy L ^c,d  

^a Department of Surgery ^*

^b Center for Surgery and Public Health   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f RAND CORPORATION   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DECISION MAKING; HEALTH FACILITY SIZE; HUMANS; INTERPROFESSIONAL RELATIONS; NEOPLASM STAGING; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; WORKLOAD;

EID: 73449146274     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181afe0c6     Document Type: Article

References (24)

1. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-1137.
2. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117-2127.
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
4. Schrag D, Cramer LD, Bach PB, et al. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000;284:3028-3035.
5. Ko CY, Chang JT, Chaudhry S, et al. Are high-volume surgeons and hospitals the most important predictors of in-hospital outcome for colon cancer resection? Surgery. 2002;132:268-273.
6. Schrag D, Panageas KS, Riedel E, et al. Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg. 2002;236:583-592.
7. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293-1300.
8. Hodgson DC, Zhang W, Zaslavsky AM, et al. Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst. 2003;95:708-716.
9. Meyerhardt JA, Catalano PJ, Schrag D, et al. Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med. 2003;139:649-657.
10. Schrag D, Panageas KS, Riedel E, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol. 2003;83:68-78; discussion 78-79.
11. Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. J Clin Oncol. 2004;22:166-174.
12. Abraham NS, Gossey JT, Davila JA, et al. Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol. 2006;101: 1320-1328.
13. Luo R, Giordano SH, Freeman JL, et al. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist. 2006;11:1025-1033.
14. Rogers SO Jr, Wolf RE, Zaslavsky AM, et al. Relation of surgeon and hospital volume to processes and outcomes of colorectal cancer surgery. Ann Surg. 2006;244:1003-1011.
15. Luo R, Giordano SH, Zhang DD, et al. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer. 2007;109:975-982.
16. Morris M, Platell C, Fritschi L, et al. Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Br J Cancer. 2007;96:701-707.
17. Birkmeyer JD, Finlayson EV, Birkmeyer CM. Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiative. Surgery. 2001;130:415-422.
18. Finlayson SR, Birkmeyer JD, Tosteson AN, et al. Patient preferences for location of care: implications for regionalization. Med Care. 1999;37:204-209.
19. Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2004;22:2992-2996.
20. National Cancer Institute. Cancer Care Outcomes Research and Surveillance Consortium. Available at: http://healthservices.cancer.gov/cancors. Accessed June 27, 2008.
21. Keating NL, Landrum MB, Klabunde CN, et al. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol. 2008;26:2532-2537.
22. Little RJ, Rubin DB. Statistical Analysis With Missing Data. 2nd ed. New York: Wiley; 2002.
23. He Y, Zaslavsky AM, Harrington DP, et al. Multiple imputation in a large-scale complex survey: a practical guide. In press.
24. Asch DA, Christakis NA, Ubel PA. Conducting physician mail surveys on a limited budget. A randomized trial comparing $2 bill versus $5 bill incentives. Med Care. 1998;36:95-99.